| |
Arthritis News Archive07-Aug-2008
Hollis-Eden Pharmaceuticals initiates Phase I/II rheumatoid arthritis trial (Pharmaceutical Business Review)
Hollis-Eden Pharmaceuticals has started a Phase I/II open label dose ranging clinical trial with its investigational oral drug candidate Triolex in patients diagnosed with rheumatoid arthritis and receiving a stable dose of methotrexate, the current standard of care in rheumatoid arthritis.
Stroke rehab may be poorer for arthritis patients (Reuters via Yahoo! News)
People with rheumatoid arthritis who suffer a stroke are likely to have lower functional ability subsequently than stroke patients without arthritis, according to a new study.
Doctors Seeing More Arthritis In Active Boomers (WCVB Boston)
They went to Woodstock, danced to rock and roll and disco music, and now active Baby Boomers are approaching retirement, many of them facing painful arthritis in their toes, feet and ankles.
Exercise Classes (Northwest Herald)
Exercise Classes Arthritis and just for the health of it chair and more exercise class, 8 to 8:45 a.m. Monday, Wednesday and Friday, McHenry County Senior Services Center, 3519 N. Richmond Road, McHenry. Arthritis Foundation certified. Information: 815-344-3555.
Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis (PR Newswire via Yahoo! Finance)
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 89 percent of surveyed rheumatologists anticipate prescribing Roche/Chugai's Actemra, following the expected launch of the drug for rheumatoid arthritis in 2009.
Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286) in Rheumatoid Arthritis ... (Business Wire via Yahoo! Finance)
SAN DIEGO----Hollis-Eden Pharmaceuticals, Inc. , the world leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, announced that it has commenced a Phase I/II open label dose ranging clinical trial with its investigational oral drug candidate TRIOLEX? in patients diagnosed with rheumatoid arthritis and receiving a stable dose of ...
Man used cannabis to ease arthritis (Fife Today)
A PITTENWEEM man who claimed he took cannabis to ease the pain of rheumatoid arthritis has been ordered to carry out 200 hours' community service. (05/08/2008 11:37:13)
Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286) in Rheumatoid Arthritis ... (Centre Daily Times)
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the world leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, announced that it has commenced a Phase I/II open label dose ranging clinical trial with its investigational oral drug candidate TRIOLEX(TM) (HE3286) in patients diagnosed with rheumatoid arthritis (RA) and receiving a ...
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|